DnB Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.46M Buy
100,876
+6,231
+7% +$410K 0.02% 426
2026
Q1
$6.74M Buy
94,645
+7,181
+8% +$566K 0.02% 377
2025
Q4
$7.17M Buy
87,464
+671
+0.8% +$52.3K 0.03% 360
2025
Q3
$6.52M Buy
86,793
+3,483
+4% +$260K 0.02% 375
2025
Q2
$6.17M Buy
83,310
+5,207
+7% +$362K 0.03% 352
2025
Q1
$6.3M Sell
78,103
-479
-0.6% -$41.2K 0.03% 331
2024
Q4
$6.14M Buy
78,582
+6,257
+9% +$532K 0.03% 348
2024
Q3
$6.79M Buy
72,325
+3,794
+6% +$318K 0.03% 336
2024
Q2
$5.34M Buy
68,531
+8,343
+14% +$681K 0.03% 343
2024
Q1
$5.47M Sell
60,188
-1,939
-3% -$161K 0.03% 339
2023
Q4
$4.8M Sell
62,127
-17,184
-22% -$1.2M 0.02% 373
2023
Q3
$5.4M Buy
79,311
+17,092
+27% +$1.24M 0.03% 340
2023
Q2
$5.05M Buy
62,219
+6,185
+11% +$494K 0.03% 353
2023
Q1
$4.6M Buy
+56,034
New +$4M 0.03% 383

Other funds holding GEHC

DnB Asset Management's GEHC Position: Q2 2026 in Review

DnB Asset Management increased its GE HealthCare (GEHC) stake by 6.6% in Q2 2026, buying an estimated $410K and bringing the position to 100,876 shares worth $6.46M. The position accounts for 0.02% of the portfolio, ranked #426.

DnB Asset Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $7.17M in Q4 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • DnB Asset Management held 100,876 shares of GE HealthCare worth $6.46M as of Q2 2026.
  • DnB Asset Management bought 6,231 GE HealthCare shares in Q2 2026, an estimated $410K.
  • GE HealthCare made up 0.02% of DnB Asset Management's portfolio in Q2 2026, its #426 holding.
  • DnB Asset Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • DnB Asset Management's GE HealthCare position peaked at $7.17M in Q4 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.